Algestone acetophenide
Drug profile
Also known as: alphasone acetophenide, deladroxone, dihydroxyprogesterone acetophenide, droxone
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Algestone acetophenide is a drug catalogued in DrugCentral.
- Molecular formula: C29H36O4; molecular weight 448.60 g/mol.
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Lupus nephritis | 35.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Algestone acetophenide is on its molecule page.
| Molecular formula | C29H36O4 |
|---|---|
| Molecular weight | 448.60 g/mol |
| CAS number | 24356-94-3 |
| InChIKey | AHBKIEXBQNRDNL-FVCOMRFXSA-N |
| PubChem CID | 5284538 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Algestone acetophenide?
Algestone acetophenide has the molecular formula C29H36O4 and a molecular weight of 448.60 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 797 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3989742 — compound record and bioactivity
- PubChem CID 5284538 — chemical identifiers
- DrugBank DB15775 — drug record
- FDA UNII OL7KC2O3OT — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.